FINWIRES · TerminalLIVE
FINWIRES

スティフェル・カナダは、バレリアーノの現地視察後、ATEXリソースの投資判断を「買い」に据え置き、目標株価を5.25カナダドルに維持した。

-- スティフェル・カナダは月曜日、チリにあるATEXリソーシズ(ATX.V)のバレリアーノ・プロジェクトを視察した後、同社の株式に対する買い推奨と目標株価5.25カナダドルを改めて表明した。 先週後半、私たちはATEXのバレリアーノ・プロジェクトを視察しました。バジェナールにあるオフィス、コア保管庫、現場キャンプなどを見学し、ATEXチームによる地質、インフラ、地域社会との連携、探査戦略に関する詳細なセミナーにも参加しました。私たちの主な収穫は2つあります。1つ目は、新興のバレリアーノ/エル・エンシエロ地区の規模です。ATEXが新たに買収したヌエボ・オリゾンテ鉱区は、銅換算で約500億~600億ポンドという目標を掲げ、チリ国内に完全に位置する未開発の斑岩鉱床群としては最大級の地位を確立するでしょう。2つ目は、探査プロセスの効率性が向上していることです。バレリアーノ鉱区の特性把握にATEXが培ってきた知見は、ヌエボ・オリゾンテ鉱区にも応用でき、探査プロセスの効率化に貢献すると考えられます。掘削シーズンは終盤に差し掛かっていますが、ATX株はバレリアーノ鉱区の斑岩鉱床のみを2024年FdS倍率で織り込んでおり、B2B(SOTP)には最小限の価値しか割り当てられていない点に留意すべきです。 「株価上昇の見込みは1株あたり6.00カナダドル」とアナリストのコール・マクギル氏は記した。 (は、北米、アジア、ヨーロッパの主要銀行および調査会社による株式、商品、経済に関する調査レポートを配信しています。調査レポート提供者の方は、こちらからお問い合わせください:https://www..com/contact-us

Price: $3.57, Change: $+0.07, Percent Change: +2.15%

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR
Research

Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.

$WAB